keyword
https://read.qxmd.com/read/38641147/borderline-rejection-to-treat-or-not-to-treat
#1
JOURNAL ARTICLE
Alessandra Palmisano, Marta D'Angelo, Ilaria Gandolfini, Marco Delsante, Giovanni Maria Rossi, Micaela Gentile, Enrico Fiaccadori, Paolo Cravedi, Umberto Maggiore
INTRODUCTION: It is unclear whether kidney transplant recipients with a biopsy diagnosis as a "borderline" acute T-cell mediated rejection (TCMR) requires the treatment with intravenous (iv) steroids pulse plus/minus intensification of the maintenance therapy (TRT) in comparison with the simple clinical follow-up (F-UP). METHODS: We retrospectively followed a consecutive series of kidney transplant recipients diagnosed with a borderline acute TCMR at biopsy by surveillance or clinical indication for 12 months and compared TRT and F-UP groups...
April 17, 2024: Transplant Immunology
https://read.qxmd.com/read/38634917/pharmacogenetic-guided-versus-standard-warfarin-dosing-for-routine-clinical-care-with-its-pharmacoeconomic-impact-a-randomized-controlled-clinical-trial
#2
JOURNAL ARTICLE
Aishwarya Anand, Naveen C Hegde, Pulkit Chhabra, Jai Purohit, Rupesh Kumar, Ankur Gupta, Deepesh P Lad, Ritin Mohindra, Saurabh Mehrotra, Rajesh Vijayvergiya, Basant Kumar, Vishal Sharma, Pankaj Malhotra, Jasmina Ahluwalia, Reena Das, Amol N Patil, Nusrat Shafiq, Samir Malhotra
BACKGROUND: Empirical use of pharmacogenetic test(PGT) is advocated for many drugs, and resource-rich setting hospitals are using the same commonly. The clinical translation of pharmacogenetic tests in terms of cost and clinical utility is yet to be examined in hospitals of low middle income countries (LMICs). AIM: The present study assessed the clinical utility of PGT by comparing the pharmacogenetically(PGT) guided- versus standard of care(SOC)- warfarin therapy, including the health economics of the two warfarin therapies...
April 18, 2024: Annals of Hematology
https://read.qxmd.com/read/38626557/effects-of-testosterone-dose-on-depression-like-behavior-among-castrated-adult-male-rats
#3
JOURNAL ARTICLE
Zhongyu Ren, Ling Xiao, Yinping Xie, Zhengyuan Huang, Shanshan Lin, Lujia Si, Gaohua Wang
Previous research has shown a decrease in serum testosterone levels in male patients with depression. In recent years, the results of testosterone replacement therapy (TRT) to improve depression have been mixed. Using the classic CUMS model, we induced depressive-like behaviors in rats and observed a decrease in their serum testosterone levels along with an increase in androgen receptor expression in the hippocampus. We then performed castration and sham surgery on male rats and found that testosterone deprivation led to the manifestation of depressive-like behavior that could be ameliorated by TRT...
April 15, 2024: Psychoneuroendocrinology
https://read.qxmd.com/read/38621521/repeatability-of-epithelium-thickness-measured-by-an-as-oct-in-different-grades-keratoconus-and-compared-to-as-oct-placido-topography
#4
JOURNAL ARTICLE
Yiran Wang, Rui Ning, Kexin Li, Huilin Xu, Yue Li, Yizhou Yang, Ingemar Gustafsson, Xingtao Zhou, Xiaomei Qu, Jinhai Huang
PURPOSE: To compare agreement of corneal epithelium thickness (ET) between AS-OCT system (RTVue, Optovue, Fremont, USA) and AS-OCT/Placido topographer (MS-39, CSO, Florence, Italy) in different stages keratoconus (KC) eyes, and to assess the repeatability of RTVue AS-OCT. DESIGN: Prospective reliability analysis. METHODS: KC eyes were classified into forme fruste KC (FFKC), mild, moderate and severe KC. Agreement was evaluated with Bland-Altman plots and 95% limits of agreement (LoA)...
April 13, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38615112/testosterone-deficiency-in-men-with-end-stage-renal-disease-and-kidney-transplantation-a-narrative-review
#5
REVIEW
Nicholas A Deebel, Ashley N Matthew, Justin Loloi, Ari P Bernstein, Nannan Thirumavalavan, Ranjith Ramasamy
Testosterone deficiency is a prevalent condition that frequently affects individuals with end-stage renal disease (ESRD) and those who have undergone renal transplantation. While the etiology of this condition is complex, its implications in this population are far-reaching, impacting various domains such as endocrine profile, sexual and erectile function, bone mineral density (BMD), anemia, and graft survival following renal transplantation. Herein, we review the most recent literature exploring the pathophysiology of testosterone deficiency in ESRD and renal transplant patients, examining its diverse effects on this demographic, and assessing the advantages of testosterone replacement therapy (TRT)...
April 13, 2024: International Journal of Impotence Research
https://read.qxmd.com/read/38606934/metabolic-effects-of-testosterone-added-to-intensive-lifestyle-intervention-in-older-men-with-obesity-and-hypogonadism
#6
JOURNAL ARTICLE
Adrian M Gonzalez-Gil, Yoann Barnouin, Alessandra Celli, Viola Viola, Marcos D Villarreal, Maria Liza Duremdes Nava, Adam Sciuk, Clifford Qualls, Reina Armamento-Villareal, Dennis T Villareal
BACKGROUND: Whether testosterone replacement therapy (TRT) conveys additional cardiometabolic benefit to an intensive lifestyle therapy (LT) in older men with obesity and hypogonadism remains unclear. OBJECTIVE: To determine whether TRT augments the effect of LT on metabolic outcomes in older men with obesity and hypogonadism. DESIGN: Secondary analysis of a randomized, double-blind, placebo-controlled trial. SETTING: Veterans Affairs Medical Center...
April 12, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38606384/a-phase-iii-single-arm-6-month-trial-of-a-wide-dose-range-oral-testosterone-undecanoate-product
#7
JOURNAL ARTICLE
James S Bernstein, Om P Dhingra
BACKGROUND: Oral testosterone undecanoate (TU) formulations may provide effective, safe, and easily titratable testosterone replacement therapy. OBJECTIVE: Demonstrate efficacy and safety of a novel oral TU formulation. DESIGN: An open-label, single-arm, multi-center trial treated 155 hypogonadal men for 180 days. Treatment began at 200 mg TU twice daily with meals; doses were titrated over two 28-day cycles to between 100 and 800 mg TU daily, measuring average testosterone (T Cavg ) after 90 days...
2024: Therapeutic Advances in Urology
https://read.qxmd.com/read/38601063/managing-catecholamine-release-syndrome-during-and-following-lu-177-dotatate-in-high-risk-pheochromocytoma-patients
#8
Tim E Phelps, Jaydira Del Rivero, Daniel S Chertow, Douglas Rosing, Karel Pacak, Frank I Lin
Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-producing tumors that express somatostatin receptors (SSTR) that can be treated with lutetium-177 DOTATATE (Lu-177-TRT); however, treatment can be associated with life-threatening cardiovascular events. A patient case with management strategies for high-risk PPGL patients receiving Lu-177-TRT is described. The 78-year-old patient with metastatic paraganglioma was enrolled and treated under NCT03206060. Deemed to be at high risk, the patient was preemptively admitted to the intensive care unit (ICU) with central line access placed...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38589271/association-between-testosterone-replacement-therapy-and-cardiovascular-outcomes-a-meta-analysis-of-30-randomized-controlled-trials
#9
REVIEW
Vikash Jaiswal, Aanchal Sawhney, Chikodili Nebuwa, Vamsikalyan Borra, Novonil Deb, Anupam Halder, Kripa Rajak, Mayank Jha, Zarghoona Wajid, Rosy Thachil, Dhrubajyoti Bandyopadhyay, Jishanth Mattumpuram, Carl J Lavie
BACKGROUND: The Cardiovascular safety of testosterone replacement therapy (TRT) among men with hypogonadism is not well established to date. Hence, we sought to evaluate the cardiovascular disease (CVD) outcomes among patients receiving testosterone therapy by using all recently published randomized controlled trials. METHODS: We performed a systematic literature search on PubMed, EMBASE, and Clinicaltrial.gov for relevant randomized controlled trials (RCTs) from inception until September 30th, 2023...
April 5, 2024: Progress in Cardiovascular Diseases
https://read.qxmd.com/read/38583494/evaluation-of-radiotherapy-treatment-plans-in-a-randomized-phase-ii-trial-comparing-two-schedules-of-twice-daily-thoracic-radiotherapy-in-limited-stage-small-cell-lung-cancer
#10
JOURNAL ARTICLE
Nina Levin, Kristin T Killingberg, Tarje O Halvorsen, Signe Danielsen, Bjørn Henning Grønberg
PURPOSE: There is limited clinical data for recommendations on how to deliver thoracic radiotherapy (TRT) concurrently with chemotherapy in limited stage (LS) small-cell lung cancer (SCLC). We reviewed radiotherapy treatment plans in a randomized phase II trial comparing high-dose with standard-dose twice-daily TRT to assess treatment planning techniques, dose-volume data for target volumes and organs at risk (OARs), evaluate compliance with the protocol, associations with radiation-induced toxicity and whether an imbalance in treatment planning parameters might be a reason for the large survival benefit of the higher dose (median overall survival 43...
April 5, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38553429/cardiovascular-safety-of-testosterone-replacement-therapy-in-men-an-updated-systematic-review-and-meta-analysis
#11
REVIEW
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Valeria Carinci, Gianni Casella, Linda Vignozzi, Alessandra Sforza, Mario Maggi
INTRODUCTION: The cardiovascular (CV) safety of testosterone (T) replacement therapy (TRT) is still conflicting. Recent data suggested a TRT-related increased risk of atrial fibrillation (AF). To systematic review and meta-analyze CV risk related to TRT as derived from placebo controlled randomized trials (RCTs). AREAS COVERED: An extensive Medline, Embase and Cochrane search was performed. All placebo-controlled RCTs reporting data on TRT-related CV safety were considered...
March 29, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38550578/low-dose-targeted-radionuclide-therapy-synergizes-with-car-t-cells-and-enhances-tumor-response
#12
JOURNAL ARTICLE
Yanping Yang, Yogindra Vedvyas, Yago Alcaina, Ju Y Son, Irene M Min, Moonsoo M Jin
Ionizing radiation has garnered considerable attention as a combination partner for immunotherapy due to its potential immunostimulatory effects. In contrast to the more commonly used external beam radiation, we explored the feasibility of combining chimeric antigen receptor (CAR) T cell therapy with targeted radionuclide therapy (TRT), which is achieved by delivering β -emitting 177 Lu-DOTATATE to tumor via tumor-infiltrating CAR T cells that express somatostatin receptor 2 (SSTR2). We hypothesized that the delivery of radiation to tumors could synergize with CAR T therapy, resulting in enhanced antitumor immunity and tumor response...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38536657/increased-risk-of-erythrocytosis-in-men-with-type-2-diabetes-treated-with-combined-sodium-glucose-cotransporter-2-inhibitor-and-testosterone-replacement-therapy
#13
JOURNAL ARTICLE
A R Gosmanov, D E Gemoets, K A Schumacher
PURPOSE: In clinical trials, sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and testosterone replacement therapy (TRT) were shown to stimulate red blood cell production. Little is known if combination therapy poses risk of erythrocytosis in real world clinical practice. METHODS: This was a retrospective nationwide cohort study of US Veterans with type 2 diabetes (T2D) and baseline hematocrit between 38 and 50% who were prescribed SGLT-2i and/or TRT between 3/2013 and 10/2022 and had adequate adherence based on the proportion of days covered > 80%...
March 27, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38534768/editorial-for-the-special-issue-molecular-biology-in-targeted-radionuclide-therapy-radiopharmaceutical-design
#14
EDITORIAL
Carlo Aprile, Onelio Geatti, Letizia Canziani, Lorenzo Lodola
Targeted radionuclide therapy (TRT) is gaining wide and rapid acceptance in clinical practice as it can deliver alpha or beta irradiation to a tumor-associated target which may be present in the tumor cell itself or in the microenvironment [...].
March 13, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38533154/easing-the-burden-of-tinnitus-a-narrative-review-for-exploring-effective-pharmacological-strategies
#15
REVIEW
Seung Ho Kim, Ikhee Kim, Hantai Kim
Many individuals seek medical attention for tinnitus, desiring relief from the distress caused by the condition; however, the treatment process is far from straightforward. The most effective treatments for chronic subjective tinnitus, such as tinnitus retraining therapy (TRT) and cognitive behavioral therapy (CBT), require considerable time and efforts. As a result, many of them express a desire for alleviation through medication. While it is true that medication is not generally recommended in treatment guidelines for chronic subjective tinnitus, in specific situations such as when accompanied by symptoms of depression or anxiety-drugs like antidepressants or anxiolytics may have a meaningful impact on symptom reduction...
February 2024: Curēus
https://read.qxmd.com/read/38527557/dual-targeting-of-tigit-and-pd-1-with-a-novel-small-molecule-for-cancer-immunotherapy
#16
JOURNAL ARTICLE
Yang Li, Beibei Li, Qingchao Wang, Xiangrui Zhang, Qiongqiong Zhang, Xiuman Zhou, Ranran Shi, Yahong Wu, Wenjie Zhai, Zhenzhen Chen, Xiaowen Zhou, Wenshan Zhao
Immune checkpoint inhibitors have unveiled promising clinical prospects in cancer treatment. Nonetheless, their effectiveness remains restricted, marked by consistently low response rates and affecting only a subset of patients. The co-blockade of TIGIT with PD-1 has exhibited substantial anti-tumor effects. Notably, there is a dearth of reports on small-molecule inhibitors concurrently targeting both TIGIT and PD-1. In this study, we employed Microscale Thermophoresis (MST) to screen our laboratory's existing repository of small molecules...
March 23, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38520748/use-of-testosterone-replacement-therapy-to-treat-long-covid-related-hypogonadism
#17
JOURNAL ARTICLE
Alessandro Amodeo, Luca Persani, Marco Bonomi, Biagio Cangiano
SUMMARY: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impair pituitary-gonadal axis and a higher prevalence of hypogonadism in post-coronavirus disease 2019 (COVID-19) patients compared with the general population has been highlighted. Here we report the first case of a patient affected with a long-COVID syndrome leading to hypogonadism and treated with testosterone replacement therapy (TRT) and its effects on clinical and quality of life (QoL) outcomes. We encountered a 62-year-old man who had been diagnosed with hypogonadotropic hypogonadism about 2 months after recovery from COVID-19 underwent a complete physical examination, general and hormonal blood tests, and self-reported questionnaires administration before and after starting TRT...
January 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38505823/impact-of-multiple-isolation-procedures-on-the-differentiation-potential-of-adipose-derived-canine-mesenchymal-stem-cells
#18
JOURNAL ARTICLE
Waleed Ak Tareen, Evelyn Saba, Usman Rashid, Adeel Sarfraz, Muhammad S Yousaf, Habib-Ur-Rehman, Hafiz F Rehman, Mansur Abdullah Sandhu
OBJECTIVE: In regenerative biology, the most commonly used cells are adipose tissue-derived mesenchymal stem cells (AD-MSCs). This is due to the abundance and easy accessibility of AD-MSCs. METHODS: In this study, canine AD-MSCs were harvested from different anatomical locations, i.e., subcutaneous (SC), omental (OM), and perirenal (PR). Various isolation techniques namely explants (TRT-I), collagenase-digestion (TRT-II), collagenase-digested explants (TRT-III), and trypsin-digested explants (TRT-IV) were used to segregate the MSCs to evaluate cell doubling time, viability, and adipogenic/osteogenic lineage differentiation potential...
2024: American Journal of Stem Cells
https://read.qxmd.com/read/38497859/effects-of-transcranial-direct-current-stimulation-combined-with-tinnitus-retraining-therapy-on-sleep-disorders-in-patients-with-chronic-tinnitus
#19
JOURNAL ARTICLE
X-D Jia, Y-K Li, C-C Xie, X-L Ding, S-G Ding, H-J Liu
OBJECTIVE: The aim of this study was to investigate the effects of transcranial direct current stimulation (TDCS) combined with tinnitus retraining therapy (TRT) on clinical efficacy and sleep disorder in patients with chronic tinnitus. PATIENTS AND METHODS: 126 patients with chronic tinnitus treated in our hospital from May 2020 to June 2022 were retrospectively analyzed. These subjects were randomly divided into two groups: the electrical stimulation group and the combined group, in line with the random table method, with 63 patients in each group...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38482115/assessment-of-systemic-inflammation-following-oral-calcium-supplementation-in-healthy-postpartum-multiparous-dairy-cows-a-randomized-controlled-trial
#20
JOURNAL ARTICLE
R Couto Serrenho, E Morrison, T C Bruinjé, S J LeBlanc
Around parturition, dairy cows inevitably and perhaps necessarily experience some degree of systemic inflammation, but when excessive or dysregulated, it may contribute to health disorders. As immune activation decreases blood Ca, greater extracellular Ca availability may potentiate or sustain inflammation. We hypothesized that in clinically healthy multiparous cows, postpartum administration of supplemental Ca would increase serum concentrations of inflammatory markers. The objective of this randomized controlled trial was to investigate a possible effect of supplementing calcium (Ca) on postpartum systemic inflammation in dairy cows...
March 2024: JDS Commun
keyword
keyword
57215
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.